Site search
Correspondence address
310 Mira Street, Stavropol, Russia, 355017
Tel
+7 865 2352511, +7 865 2353229.
E-mail
medvestnik@stgmu.ru
The journal is included into The list of leading scientific periodicals.
The journal is included into VINITI database and is registered in Electronic scientific library.
The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.
[Pediatrics]
Lyudmila Barycheva; Anna Khodzhayan; Andrey Anatolyevich Puchkov; Leila Ibragimovna Bachieva; Natalia Alexandrovna Kozmova; Lyudmila Sergeevna Khachirova;
This study presents a review of the results obtained through expanded screening of newborns in Stavropol Region embracing a period of over 2.5 years, during which abnormal biomarker levels were detected in 25 out of 61391 newborns. Molecular genetic testing identified congenital immune disorders in 8 infants, indicating an overall prevalence rate of 1:7674 in Stavropol Region. The frequency of severe combined immunodeficiency and syndromic immunodeficiencies was 1:20464, while antibody deficiency issues accounted for 1:30695. The implementation of the screening has improved primary immunodeficiency diagnostics and serves as an important tool for investigating their genetic structure within the region.
References:
1. Deng M., Mao H. Inborn errors of immunity in mainland China: the past, present and future. BMJ Paediatr. Open. 2023;7(1):e002002. https://doi.org/10.1136/bmjpo-2023-002002
2. Tangye S. G., Al-Herz W., Bousfiha A., Cunningham Rundles C., Franco J. L. [et al.]. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J. Clin. Immunol. 2022;42(7):1473-1507. https://doi.org/10.1007/s10875-022-01289-3
3. Solis L., Van Coillie S., Bonham J. R., Hauck F., Hammarström L. [et al.]. Newborn Screening Today and Tomorrow: A Brief Report from the International Primary Immunodeficiencies Congress. Int. J. Neonatal. Screen. 2024;10(2):30. https://doi.org/10.3390/ijns10020030
4. Kumarasamy G., Khairiz K., Chang W. L., Aye T. T., Ali A. Paving the way in implementation of SCID newborn screening in developing nations: feasibility study and strategies to move forward in Malaysia. Front. Immunol. 2024;15:1400247. https://doi.org/10.3389/fimmu.2024.1400247
5. Yoo N., Kim S., Kim J., Ahn J. G., Kang I. [et al.]. The clinical and socioeconomic aspects of t-cell receptor excision circle based newborn screening for severe combined immunodeficiency in Southeast and East Asia. Front. Immunol. 2025;16:1549768. https://doi.org/10.3389/fimmu.2025.1549768
6. Bloomfield M., Hlaváčková E., Schneiderová H., Turnovec M., Tichý L. [et al.]. Beyond TREC: Pivotal role of tandem TREC/KREC assay in Czech SCID NBS pilot programme. Pediatr. Allergy Immunol. 2025;36(5):e70100. https://doi.org/10.1111/pai.70100
7. Voronin S. V., Zinchenko R. A., Efimova I. Yu., Kutsev S. I., Marakhonov A. V. [et al.]. Neonatal screening, postnatal diagnosis and tactics of preclinical treatment and prevention of primary immunodeficiencies in children. Pediatrija im. G. N. Speranskogo. – Pediatrian. a. G. N. Speransky. 2023;102(2):11-33. (In Russ.). https://doi.org/10.24110/0031-403X2023-102-2-11-33
8. Gizewska M., Durda K., Winter T. Newborn screening for SCID and other severe primary immunodeficiency in the Polish-German transborder area: experience from the first 14 months of collaboration. Front. Immunol. 2020;11:1948.
9. Göngrich C., Ekwall O., Sundin M., Brodszki N., Fasth A. [et al.]. First year of TREC-based national SCID screening in Sweden. Int. J. Neonatal. Screen. 2021;7(3):59. https://doi.org/10.3390/ijns7030059
10. Barycheva L. Yu., Khachirova L. S., Kubanova L. T., Dushchina L. V., Mukhina A. A. Register of primary immunodeficiency in the Stavropol territory. Meditsinskii vestnik Severnogo Kavkaza. – Medical News of North Caucasus. 2019;14(4):693-695. (In Russ.). https://doi.org/10.14300/mnnc.2019.14171
11. Barycheva L. Yu., Khachirova L. S., Kubanova L. T., Kalyuzhin O. V., Golubeva M. V. Detection of T-cell receptor excision circles and κ-deleting recombination excision circles in the diagnosis of primary immunodeficiency: retrospective analysis of clinical cases. Voprosy prakticheskoj pediatrii. – Clinical Practice in Pediatrics. 2019;14(6):98-103. (In Russ.). https://doi.org/10.20953/1817-7646-2019-6-98-103
12. Kwan A., Abraham R. S., Currier R., Brower A., Andruszewski K. [et al.]. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312(7):729-738. https://doi.org/10.1001/jama.2014.9132
13. Lankester A. C., Neven B., Mahlaoui N., von Asmuth E. G. J., Courteille V. [et al.]. Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006–2014 European cohort. J. Allergy Clin. Immunol. 2022;149:1744-1754.e8. https://doi.org/10.1016/j.jaci.2021.10.017
14. Marakhonov A. V., Efimova I. Y., Mukhina A. A., Zinchenko R. A., Balinova N. V. [et al.]. Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns. J. Clin. Immunol. 2024;44(4):93. https://doi.org/10.1007/s10875-024-01691-z
15. Thakar M. S., Logan B. R., Puck J. M. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the primary immune deficiency treatment consortium. Lancet. 2023;402:129-140.
16. Vakkilainen S., Taskinen M., Mäkitie O. Immunodeficiency in cartilage-hair hypoplasia: Pathogenesis, clinical course and management. Scand. J. Immunol. 2020;92(4):e12913. https://doi.org/10.1111/sji.12913
17. Pello E., Kainulainen L., Vakkilainen M., Klemetti P., Taskinen M. [et al.]. Shorter birth length and decreased T-cell production and function predict severe infections in children with non-severe combined immunodeficiency cartilage-hair hypoplasia. J. Allergy Clin. Immunol. Glob. 2023;3(1):100190. https://doi.org/10.1016/j.jacig.2023.100190
18. Kuhn K., Lederman H. M., McGrath-Morrow S. A. Ataxiatelangiectasia clinical trial landscape and the obstacles to overcome. Expert Opin Investig Drugs. 2023;32(8):693-704. https://doi.org/10.1080/13543784.2023.2249399
19. Currier R., Puck J. M. SCID newborn screening: what we’ve learned. J. Allergy Clin. Immunol. 2021;147:417-426. 20.
20. Bahal S., Zinicola M., Moula S. E., Whittaker T. E., Schejtman A. [et al.]. Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia. J. Allergy Clin. Immunol. 2024;154:195-208.e8. https://doi.org/10.1016/j.jaci.2024.03.003
21. Blom M., Bredius R. G. M., van der Burg M. EfÏcient screening strategies for severe combined immunodeficiencies in newborns. Expert Rev. Mol. Diagn. 2023;23(9):815-825. https://doi.org/10.1080/14737159.2023.2244879
22. Barbaro M., Ohlsson A., Borte S., Jonsson S., Zetterström R. H. [et al.]. Newborn screening for severe primary immunodeficiency diseases in Sweden – a 2-year pilot TREC and KREC screening study. J. Clin. Immunol. 2017;37:51-60. https://doi.org/10.1007/s10875-016-0347-5
23. Bachiyeva L. I., Barycheva L. Yu., Zhetishev R. A., Obedin A. N. TREC, KREC as potential predictors for infection development in preterm infants: a single-center study. Pediatrija im. G. N. Speranskogo. – Pediatria n. a. G. N. Speransky. 2025;104(1):45-54. (In Russ.). https://doi.org/10.24110/0031- 403X-2025-104-1-45-54
24. Barycheva L. Y., Bachieva L. I., Puchkov A. A., Selezneva J. G., Kozmova N. A. TREC and KREC values in patients with congenital heart defects – neonatal screening data. Allergologija i immunologija v pediatrii. – Allergology and Immunology in Pediatrics. 2024;3:42-53. (In Russ.). https://doi.org/10.53529/2500-1175-2024-3-42-53
25. Eissa E., Afifi H. H., Abo-Shanab A. M., Thomas M. M., Taher M. B. [et al.]. Importance of TREC and KREC as molecular markers for immunological evaluation of down syndrome children. Sci. Rep. 2023;13(1):15445. https://doi.org/10.1038/s41598-023-42370-0
Keywords: newborn screening, inborn errors of immunity, TREC, KREC